Director sale of modest size relative to market cap, no material signal. Monitor for any subsequent Form 4 filings to confirm execution and for any cluster of insider selling ahead of upcoming catalysts.
Price Chart
Executive Summary
Director Julia P. Gregory filed a Form 144 notice of intent to sell 22,583 shares of Nurix Therapeutics common stock, with an approximate market value of $528,528 based on the filing date. The shares are to be sold through Morgan Stanley and were acquired via stock option exercise. As a director sale, this is a routine insider transaction with limited signal value absent additional context.
Key Facts
- Form 144 filed by Director Julia P. Gregory on October 14, 2026
- Proposed sale of 22,583 shares of common stock
- Estimated aggregate market value of $528,528
- Shares acquired via stock option exercise on the same date
- Sale to be executed through Morgan Stanley Smith Barney
Financial Impact
Proposed sale of 22,583 shares valued at approximately $528,528, less than 0.5% of outstanding shares based on the issuer's market cap of ~$109 million
Risk Factors
- Insider sale may signal lack of confidence if followed by additional director or officer sales
- Option-exercise-and-sell pattern is common for tax planning and does not necessarily indicate bearish view
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010217 |
| Document: 0001950047-26-010217-index.html | 0001950047-26-010217 |
| Document: 0001950047-26-010217.txt | 0001950047-26-010217 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 13d ago | Insider Cluster | $24.42 | awaiting T+20 | awaiting T+20 | $27.26 (+11.63%) |
Oct 14, 2026 14d ago | 144 | $24.95 | awaiting T+20 | awaiting T+20 | $27.26 (+9.26%) |
Oct 13, 2026 15d ago | 8-K | $22.13 | awaiting T+20 | awaiting T+20 | $27.26 (+23.18%) |
Oct 5, 2026 23d ago | Press Release | $22.88 | awaiting T+20 | awaiting T+20 | $27.26 (+19.14%) |
Sep 23, 2026 5w ago | SC 13G | $23.65 $25.51 | ▲ +7.86% | ▲ +8.28% | $27.26 (+15.26%) |
Sep 2, 2026 8w ago | Insider Cluster | $25.32 $22.99 | ▼ −9.20% | ▼ −8.01% | $27.26 (+7.66%) |
Aug 5, 2026 12w ago | Insider Cluster | $25.22 | awaiting T+20 | awaiting T+20 | $27.26 (+8.09%) |
Aug 5, 2026 12w ago | Insider Cluster | $25.12 | awaiting T+20 | awaiting T+20 | $27.26 (+8.52%) |
Aug 4, 2026 12w ago | Insider Cluster | $25.12 | awaiting T+20 | awaiting T+20 | $27.26 (+8.52%) |
Aug 3, 2026 12w ago | Insider Cluster | $24.69 | awaiting T+20 | awaiting T+20 | $27.26 (+10.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers